Y mAbs Therapeutics Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Y mAbs Therapeutics cash flow reinvestment rate. Y mAbs Therapeutics (YMAB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $1.65 Million. Explore YMAB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$1.65 Million
USD
Capital Expenditures
$0.00
USD
Y mAbs Therapeutics Cash Flow Reinvestment Rate by Year (None–None)
Y mAbs Therapeutics cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Y mAbs Therapeutics. For the full cash flow conversion analysis, see cash flow conversion of Y mAbs Therapeutics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow